LISATA THERAPEUTICS, INC. Accumulated Other Comprehensive Income
LISATA THERAPEUTICS, INC. (LSTA) had Accumulated Other Comprehensive Income of -$17.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax · last filed 2026-08-06
- 2026-06-30: Accumulated Other Comprehensive Income (Loss), Net of Tax -$17.00K.
- 2026-03-31: Accumulated Other Comprehensive Income (Loss), Net of Tax -$21.00K.
- 2025-12-31: Accumulated Other Comprehensive Income (Loss), Net of Tax -$37.00K.
- 2025-09-30: Accumulated Other Comprehensive Income (Loss), Net of Tax -$42.00K.
| Period end | Accumulated Other Comprehensive Income (Loss), Net of Tax | Accumulated Other Comprehensive Income (Loss), Net of Tax as first filed |
|---|---|---|
| 2026-06-30 | -$17.00K 10-Q · filed 2026-08-06 | |
| 2026-03-31 | -$21.00K 10-Q · filed 2026-05-11 | |
| 2025-12-31 | -$37.00K 10-Q · filed 2026-08-06 | |
| 2025-09-30 | -$42.00K 10-Q · filed 2025-11-06 | |
| 2025-06-30 | -$50.00K 10-Q · filed 2025-08-07 | |
| 2025-03-31 | -$78.00K 10-Q · filed 2025-05-08 | |
| 2024-12-31 | -$81.00K 10-K · filed 2026-03-12 | |
| 2024-09-30 | -$32.00K 10-Q · filed 2024-11-12 | |
| 2024-06-30 | -$77.00K 10-Q · filed 2024-08-12 | |
| 2024-03-31 | -$104.00K 10-Q · filed 2024-05-09 | |
| 2023-12-31 | -$42.00K 10-K · filed 2025-02-27 | |
| 2023-09-30 | -$100.00K 10-Q · filed 2023-11-02 | |
| 2023-06-30 | -$50.00K 10-Q · filed 2023-08-14 | |
| 2023-03-31 | -$52.00K 10-Q · filed 2023-05-09 | |
| 2022-12-31 | -$29.00K 10-K · filed 2024-02-29 | |
| 2022-09-30 | -$90.00K 10-Q · filed 2022-11-10 | |
| 2022-06-30 | -$70.00K 10-Q · filed 2022-08-04 | |
| 2022-03-31 | -$196.00K 10-Q · filed 2022-05-05 | |
| 2021-12-31 | -$70.00K 10-K · filed 2023-03-30 | |
| 2021-09-30 | -$64.00K 10-Q · filed 2021-11-04 | |
| 2021-06-30 | -$17.00K 10-Q · filed 2021-08-05 | |
| 2021-03-31 | -$72.00K 10-Q · filed 2021-05-06 | |
| 2020-12-31 | -$13.00K 10-K · filed 2022-03-22 | |
| 2020-09-30 | -$12.00K 10-Q · filed 2020-11-05 | |
| 2020-06-30 | -$7.00K 10-Q · filed 2020-08-13 | |
| 2020-03-31 | $0.00 10-Q · filed 2020-05-07 | |
| 2019-12-31 | $2.00K 10-K · filed 2021-02-25 | |
| 2019-09-30 | $2.00K 10-Q · filed 2019-11-06 | |
| 2019-06-30 | $0.00 10-Q · filed 2019-08-08 | |
| 2019-03-31 | -$18.00K 10-Q · filed 2019-05-09 | |
| 2018-12-31 | -$32.00K 10-K · filed 2020-03-05 | |
| 2018-09-30 | -$28.62K 10-Q · filed 2018-11-08 | |
| 2018-06-30 | -$31.09K 10-Q · filed 2018-08-09 | |
| 2018-03-31 | -$58.72K 10-Q · filed 2018-05-10 | |
| 2017-12-31 | -$28.00K 10-K · filed 2019-03-14 | -$27.98K 10-K · filed 2018-03-22 |
| 2017-09-30 | -$28.72K 10-Q · filed 2017-11-09 | |
| 2017-06-30 | -$57.86K 10-Q · filed 2017-08-10 | |
| 2016-12-31 | $0.00 10-K · filed 2018-03-22 | |
| 2012-12-31 | $0.00 10-K · filed 2013-03-11 | |
| 2012-09-30 | $4.15M 10-Q · filed 2012-11-13 | |
| 2012-06-30 | $4.17M 10-Q · filed 2012-08-14 | |
| 2012-03-31 | $4.16M 10-Q · filed 2012-05-11 | |
| 2011-12-31 | $4.15M 10-K · filed 2013-03-11 | |
| 2011-09-30 | $5.00M 10-Q · filed 2011-11-10 | |
| 2011-06-30 | $4.29M 10-Q · filed 2011-08-12 | |
| 2010-12-31 | $2.78M 8-K · filed 2012-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| BIOVIE INC. (BIVI) | United States | $0.012B |